Stock A068270 CELLTRION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Dividend Celltrion, Inc.

Equities

A068270

KR7068270008

End-of-day quote Korea S.E.
Other stock markets
 06/09/2024 		5-day change 1st Jan Change
191,200.00 KRW +1.70% Intraday chart for Celltrion, Inc. -5.81% -5.11%
08-29 Celltrion Usa Partners with Express Scripts and Cigna Healthcare to Expand Access to Zymfentra® (Infliximab-Dyyb), the First and Only Fda-Approved Subcutaneous Infliximab on Their Medical Benefit Formulary CI
08-26 European Commission Approves Celltrion's SteQeyma (CT-P43) A Biosimilar to Stelara (ustekinumab), for the Treatment of Multiple Chronic Inflammatory Diseases CI

EPS & Dividend: Celltrion, Inc.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Dividend per Share 2 - - 721.2 - 500 500 507.1 550.3
Rate of return - - 0.38% - 0.25% 0.26% 0.27% 0.29%
EPS 2 2,153 3,586 4,031 3,855 3,753 2,569 6,031 8,172
Distribution rate - - 17.9% - 13.3% 19.5% 8.41% 6.73%
Reference price 2 167,280.34 338,423.83 190,384.62 160,500.00 201,500.00 191,200.00 191,200.00 191,200.00
Nbr of stocks (in thousands) 144,521 144,757 144,931 143,304 138,811 206,358 - -
Announcement Date 19/02/20 22/02/21 16/02/22 03/03/23 29/02/24 - - -
1KRW in Million2KRW
Estimates

Past dividends: Celltrion, Inc.

26/12/2023 Annual 500 KRW
27/12/2022 Annual 375 KRW
28/12/2021 Annual 750 KRW

Upcoming events: Celltrion, Inc.

10/11/2024 Q3 2024 Earnings Release (Projected)
06/04/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)
06/05/2026 Q1 2026 Earnings Release (Projected)
More events

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Yield (Y) Yield (Y+1) P/E ratio Price to Book EV / Sales
CELLTRION, INC. Stock Celltrion, Inc.
+0.26%+0.27%74.43x 2.344 11.32x
LONZA GROUP AG Stock Lonza Group AG
+0.86%+0.99%46.75x 4.013 6.21x
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-.--%-.--%31.55x 6.333 3.62x
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-.--%-.--%-101.86x 118.66 13.66x
MODERNA, INC. Stock Moderna, Inc.
-.--%-.--%-7.94x 2.666 6.51x
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
-.--%-.--%32.72x 2.493 3.22x
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
-.--%-.--%13.96x 2.068 4.61x
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.45%+0.47%59.5x 4.860 9.24x
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
-.--%-.--%28.97x 10.91 4.52x
QIAGEN N.V. Stock Qiagen N.V.
-.--%-.--%49.19x 2.665 5.16x
Average +0.16% +0.17% 22.73x 15.7 6.81x
Weighted average by Cap. +0.21% +0.23% 19.08x 18.51 6.96x
See all sector dividends

Dividend / Share (DPS) - Evolution of Analysts' Estimates

More analyst reviews

Dividend / Share (DPS) - Estimates Revisions

Estimates Revisions:
More analyst reviews

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

More analyst reviews

Quarterly earnings -

Company calendar

Annual Profit -

Company calendar
  1. Stock Market
  2. Equities
  3. A068270 Stock
  4. Valuation Celltrion, Inc.
  5. Dividend
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition